Bioharvest Sciences Inc.
BHST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723464
No open-market purchases or sales by Bioharvest Sciences Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $4.80M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Bioharvest Sciences Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +13 vs. Q3 2025
- Shares held
- 1.63M
- +1.37M (+531.0%) vs. Q3 2025
- Total value
- $8.48M
- +$6.04M (+247.7%) vs. Q3 2025
- New holders
- 14
- 2 more added
- Sold out
- 1
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BHST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $4.80M |
| Q1 2026 | 20 | $7.38M |
| Q4 2025 | 22 | $8.48M |
| Q3 2025 | 9 | $2.44M |
| Q2 2025 | 8 | $724.7K |
| Q1 2025 | 8 | $802.6K |
| Q4 2024 | 6 | $545.4K |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Bioharvest Sciences Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 757,064 | $3.93M | 0.01% | +757,064 | New |
| Thompson Siegel & Walmsley LLC | 374,717 | $1.95M | 0.03% | +374,717 | New |
| Evercore Wealth Management, LLC | 139,470 | $723.8K | 0.01% | +139,470 | New |
| Magnus Financial Group LLC | 55,000 | $285.4K | 0.02% | 00.0% | Unchanged |
| King Luther Capital Management Corp | 40,000 | $207.6K | 0.00% | +40,000 | New |
| Advisor Group Holdings, Inc. | 35,233 | $182.9K | 0.00% | +34,605+5,510.4% | Added |
| True North Advisors, LLC | 34,928 | $181.3K | 0.02% | −133,085−79.2% | Reduced |
| XTX Topco Ltd | 33,275 | $172.7K | 0.00% | +33,275 | New |
| Jane Street Group, LLC | 27,998 | $145.3K | 0.00% | +27,998 | New |
| Quadrature Capital Ltd | 27,065 | $140.5K | 0.00% | +27,065 | New |
| Marshall Wace, LLP | 21,235 | $110.2K | 0.00% | +21,235 | New |
| Citadel Advisors LLC | 15,367 | $79.8K | 0.00% | +15,367 | New |
| Susquehanna International Group, LLP | 14,737 | $76.5K | 0.00% | +14,737 | New |
| HRT Financial LP | 14,632 | $75.0K | 0.00% | +14,632 | New |
| Geode Capital Management, LLC | 11,811 | $61.3K | 0.00% | +11,811 | New |
| TD Waterhouse Canada Inc. | 12,042 | $60.8K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 11,556 | $60.0K | 0.00% | +11,556 | New |
| Morgan Stanley | 3,250 | $16.9K | 0.00% | +3,239+29,445.5% | Added |
| Royal Bank of Canada | 3,009 | $16.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,173 | $6.09K | 0.00% | +1,173 | New |
| National Bank of Canada | 154 | $777 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 76 | $385 | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |